DOCSLIB.ORG

"Description"" ""Generatio"

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TABLE S3 "ID ""Description"" ""GeneRatio"" ""BgRatio"" ""pvalue"" ""p.adjust"" ""qvalue"" ""geneID"" ""Count""" "GO:0060485 ""GO:0060485"" ""mesenchyme development"" ""57/1866"" ""269/23239"" 9.4636789495672e-12 5.38861879388356e-08 4.37819673508925e-08 ""Bmpr2/Erbb4/Clasp1/Mdm4/Adipor1/Cited2/Hdac2/ Gja1/Kitl/Pawr/Hnrnpab/Anxa6/Tmem100/Ddx5/Axin2/Osr1/Zfp36l1/Mef2c/ Fgf9/Gata4/Ddx17/Hes1/Sema5b/Phldb2/Robo2/Tiam1/Erg/Sox8/Bambi/ Ldlrad4/Smad7/Pax2/Nckap1/Wt1/Sema6d/Il1b/Pax1/Fam83d/Sema6c/Sdcbp/ Trim62/Sema3c/Coro1c/Tbx5/Smo/Dact3/Sema4b/Wnt11/Folr1/Tead1/Dand5/ Nup133/Yap1/Sema7a/Nedd4/Clasp2/Ctnnb1"" 57" "GO:0016570 ""GO:0016570"" ""histone modification"" ""70/1866"" ""422/23239"" 4.63618683746812e-09 1.12414845920283e-05 9.13358933354856e-06 ""Zfp451/Trip12/Rbbp5/Smyd3/Hdac2/Sirt1/Jmjd1c/ Yeats4/Usp15/Cdk2/Lif/Srebf1/Aurkb/Kdm6b/Suz12/Atxn7l3/Wbp2/Hdac9/ Prkd1/Brms1l/Arid4a/Jdp2/Arid4b/Hist1h1c/Atxn7/Usp16/Brpf3/Kat2b/Mta3/ Epc1/Wac/Kdm3b/Kmt5b/Kdm2a/Suv39h2/Bmi1/Ehmt1/Wdr5/Rif1/Eid1/Ncoa6/ Phf20/Zfp335/Jade1/Ash1l/Setdb1/Eya3/Paxip1/Rest/Mtf2/Sart3/Kdm2b/ Kdm7a/Prdm5/Kdm3a/Ruvbl1/Rybp/Sgf29/Setd1a/Sin3b/Pkn1/Taf5l/Morf4l1/ Msl2/Wdr82/Ctnnb1/Hdac6/Jade3/Tbl1x/Phf8"" 70" "GO:0016569 ""GO:0016569"" ""covalent chromatin modification"" ""71/1866"" ""433/23239"" 5.92280536987791e-09 1.12414845920283e-05 9.13358933354856e-06 ""Zfp451/Trip12/Rbbp5/Smyd3/Hdac2/Sirt1/Jmjd1c/ Yeats4/Usp15/Cdk2/Lif/Srebf1/Aurkb/Kdm6b/Suz12/Atxn7l3/Wbp2/Dnmt3a/ Hdac9/Prkd1/Brms1l/Arid4a/Jdp2/Arid4b/Hist1h1c/Atxn7/Usp16/Brpf3/ Kat2b/Mta3/Epc1/Wac/Kdm3b/Kmt5b/Kdm2a/Suv39h2/Bmi1/Ehmt1/Wdr5/Rif1/ Eid1/Ncoa6/Phf20/Zfp335/Jade1/Ash1l/Setdb1/Eya3/Paxip1/Rest/Mtf2/ Sart3/Kdm2b/Kdm7a/Prdm5/Kdm3a/Ruvbl1/Rybp/Sgf29/Setd1a/Sin3b/Pkn1/ Taf5l/Morf4l1/Msl2/Wdr82/Ctnnb1/Hdac6/Jade3/Tbl1x/Phf8"" 71" "GO:0061564 ""GO:0061564"" ""axon development"" ""76/1866"" ""483/23239"" 1.10467424874716e-08 1.57250379309158e-05 1.27764297980099e-05 ""Trak2/Bmpr2/Actr3/Cxcr4/Enah/Ust/Plxnc1/Fstl4/ Rtn4rl1/Rab10/Nrcam/Sipa1l1/Flrt2/Mtr/Ptch1/Zswim6/Vcl/Atp8a2/Fzd3/ Dpysl2/Slitrk1/Slitrk5/Stk24/Kalrn/Sema5b/Robo2/App/Tiam1/Ddr1/ Hsp90ab1/Ptprm/Nrep/Myo5b/Rnf165/Ablim1/Shtn1/Kif5c/Sema6d/Adnp/Skil/ Sema6c/Ngf/Plppr4/Epha7/Klf4/Trim32/Nfib/Jun/Sema3c/Nkx6-1/Ssh1/ Ptpn11/Actb/Smo/Ctnna2/Plxna1/Arhgap35/Igf1r/Sema4b/Picalm/Folr1/ Unc5d/Nrg1/Rab3a/Pou4f2/Tubb3/Disc1/Nectin1/Zpr1/Sema7a/Rab11a/Clasp2/ Trak1/Hdac6/Xk/Pak3"" 76" "GO:1903311 ""GO:1903311"" ""regulation of mRNA metabolic process"" ""46/1866"" ""241/23239"" 2.92835523104614e-08 3.15705416537512e-05 2.56507367992599e-05 ""Gigyf2/Dhx9/Rc3h1/Hnrnpu/Larp1/Cnot8/Srsf1/ Ddx5/Axin2/Srsf2/Zfp36l1/Zc3h14/Hnrnpk/Ddx17/Tnrc6b/Wtap/Srsf7/ Zfp36l2/Celf4/Malat1/Cpeb3/Celf2/Fxr1/Noct/Dhx36/Mov10/Rbm15/Mettl14/ Virma/Pabpc4/Srsf10/Srpk2/Rest/Cnot6l/Hnrnpd/Sart3/Rbm19/Zc3hav1/Tia1/ Dhx34/Supt5/Samd4b/Hnrnpl/Cnot7/Rbmxl1/Sltm"" 46" "GO:0071560 ""GO:0071560"" ""cellular response to transforming growth factor beta stimulus"" ""40/1866"" ""200/23239"" 6.14982587855302e-08 3.89078983916454e-05 3.16122628494041e-05 ""Zfp451/Bmpr2/Actr3/Cited2/ Ptprk/Fyn/Sirt1/Usp15/Mtmr4/Ppm1a/Fut8/Zfp36l1/Mef2c/Map3k1/Tab1/ Itgb5/Hsp90ab1/Zfp36l2/Bambi/Nrep/Ldlrad4/Smad7/Got1/Acvr2a/Pmepa1/ Skil/Trim33/Sdcbp/Map3k7/Jun/Rasl11b/Sox5/Igf1r/Folr1/Snx25/Hpgd/ Dand5/Skor1/Rnf111/Cd109"" 40" "GO:0010769 ""GO:0010769"" ""regulation of cell morphogenesis involved in differentiation"" ""56/1866"" ""333/23239"" 9.85724339736616e-08 5.61271439046029e-05 4.56027207699203e-05 ""Stau2/Hecw2/Trak2/Bmpr2/ Actr3/Dnm3/Ust/Lims1/Plxnc1/Fstl4/Sipa1l1/Rreb1/Nedd9/Zswim6/Dpysl2/ Slitrk1/Rap2a/Triobp/Kalrn/Sema5b/Robo2/Tiam1/Ttc3/Myo5b/Shtn1/Sema6d/ Adnp/Skil/Sema6c/Ngf/Ppp3ca/Pdlim5/Sh3glb1/Epha7/Ptprd/Sema3c/Ywhah/ Nkx6-1/Coro1c/Ssh1/Ppp1r9a/Plxna1/Arhgap35/Ube3a/Sema4b/Picalm/Nrg1/ Pou4f2/Disc1/Sema7a/Rab11a/Nedd4/Clasp2/Trak1/Xk/Pak3"" 56" "GO:0071559 ""GO:0071559"" ""response to transforming growth factor beta"" ""40/1866"" ""205/23239"" 1.23823907563773e-07 6.40957572425567e-05 5.20771362433285e-05 ""Zfp451/Bmpr2/Actr3/Cited2/ Ptprk/Fyn/Sirt1/Usp15/Mtmr4/Ppm1a/Fut8/Zfp36l1/Mef2c/Map3k1/Tab1/ Itgb5/Hsp90ab1/Zfp36l2/Bambi/Nrep/Ldlrad4/Smad7/Got1/Acvr2a/Pmepa1/ Skil/Trim33/Sdcbp/Map3k7/Jun/Rasl11b/Sox5/Igf1r/Folr1/Snx25/Hpgd/ Dand5/Skor1/Rnf111/Cd109"" 40" "GO:0050808 ""GO:0050808"" ""synapse organization"" ""66/1866"" ""424/23239"" 1.52046254744849e-07 7.21459478764309e-05 5.86178324213694e-05 ""Stau2/Erbb4/Actr3/Dnm3/Utrn/Fyn/Zfp365/Arf1/ Sez6/Nrcam/Arf6/Sipa1l1/Flrt2/Hnrnpk/Mef2c/Htr1a/Slitrk1/Slitrk5/ Ywhaz/Kalrn/App/Tiam1/Synpo/Myo5b/Malat1/Flrt1/Tanc1/Rapgef4/Adnp/ Slc7a11/Pfn2/Pdlim5/Adgrl2/Sdcbp/Epha7/Lingo2/Unc13b/Ptprd/Nfia/Wasf2/ Fzd1/Sept11/Ssh1/Actb/Ppp1r9a/Wasl/Lrrc4/Ctnna2/Dctn1/Vhl/Ube3a/Igf1r/ Picalm/Insr/Col4a1/Nrg1/Rab3a/Adgrl1/Disc1/Mtmr2/Kirrel3/Nectin1/ Nedd4/Ctnnb1/Hdac6/Pak3"" 66" "GO:0031346 ""GO:0031346"" ""positive regulation of cell projection organization"" ""69/1866"" ""454/23239"" 2.02730340431832e-07 8.87958891091424e-05 7.2145736534243e-05 ""Stau2/Bmpr2/Actr3/Cxcr4/ Rgs2/Dnm3/Ahi1/Fyn/Snx3/Sirt1/Plxnc1/Nav3/Grip1/Lif/Ccdc88a/Arf1/Sez6/ Nf1/Itsn2/Prkd1/Rala/Ripor2/Rreb1/Hnrnpk/Enc1/Atp8a2/Slitrk1/Stk24/ Kctd17/Cdc42ep1/Kalrn/Robo2/Tiam1/Kat2b/Myo5b/Cpeb3/Shtn1/Nfe2l2/ Nckap1/Adnp/Skil/Il2/Ngf/Sh3glb1/Ptprd/Wasf2/Fzd1/Scarb2/Coro1c/ Mapkapk5/Hspb1/Ppp1r9a/Wasl/Plxna1/Brk1/Eps8/Arhgap35/Igf1r/Picalm/ Nrg1/Crtc1/Pou4f2/Disc1/Sema7a/Rab11a/Mapk6/Eef1a1/Trak1/Pak3"" 69" "GO:0007178 ""GO:0007178"" ""transmembrane receptor protein serine/ threonine kinase signaling pathway"" ""57/1866"" ""350/23239"" 2.31549625085626e-07 9.41581075096542e-05 7.6502483224249e-05 ""Zfp451/Bmpr2/Inhbb/Grem2/Cited2/Akap7/Ptprk/Sirt1/Fstl3/Usp15/Gdf11/ Mtmr4/Tmem100/Ddx5/Ppm1a/Fut8/Map3k1/Fgf9/Gata4/Tab1/Hes1/Itgb5/Lnpep/ Hsp90ab1/Tgif1/Bambi/Nrep/Egr1/Ldlrad4/Smad7/Rnf165/Dmrt1/Got1/Tcf7l2/ Acvr2a/Pmepa1/Skil/Slc33a1/Ppm1l/Hfe2/Notch2/Trim33/Sdcbp/Map3k7/Jun/ Fzd1/Rasl11b/Folr1/Rbpms/Snx25/Hpgd/Mir23a/Dand5/Bmper/Skor1/Rnf111/ Cd109"" 57" "GO:0001667 ""GO:0001667"" ""ameboidal-type cell migration"" ""63/1866"" ""403/23239"" 2.48045594071797e-07 9.41581075096542e-05 7.6502483224249e-05 ""Map4k4/Bmpr2/Erbb4/Clasp1/Actr3/Cxcr4/Adipor1/ Sirt1/Arid5b/Kitl/Anxa6/Cenpv/Nf1/Hdac9/Prkd1/Arf6/Syne2/Rreb1/Mef2c/ Nr4a1/Sp1/Sema5b/Smoc2/Sox8/Ptprm/Fgf1/Pkn3/Nfe2l2/Nckap1/Spred1/ Sema6d/Pfn2/Sema6c/Pkn2/Klf4/Jun/Cap1/Macf1/Wasf2/Plekhg5/Sema3c/ Paxip1/Coro1c/Ptpn11/P2rx4/Scarb1/Hspb1/Hmgb1/Smo/Adamts9/Vhl/Sema4b/ Gab2/Wnt11/Folr1/Pik3c2a/Pkn1/Bmper/Sema7a/Rab11a/Clasp2/Hdac6/Pak3"" 63" "GO:0009896 ""GO:0009896"" ""positive regulation of catabolic process"" ""62/1866"" ""401/23239"" 4.55545919342675e-07 0.000150226780922851 0.000122057697327922 ""Hecw2/Rufy4/Gigyf2/Atg4b/ Rab3gap1/Cop1/Rc3h1/Epm2a/Rnf217/Gja1/Supv3l1/Sirt1/Sgta/Irgm1/Larp1/ Cnot8/Trib2/Prkd1/Zfp36l1/Lpcat1/Trim13/Rnf19a/Rnf139/Tnrc6b/Prickle1/ Crebrf/Bag6/Zfp36l2/Wac/Ndfip1/Csnk1a1/Smad7/Fam122a/Il33/Cpeb3/ Ambra1/Il1b/Ptpn1/Dhx36/Mov10/Mettl14/Sh3glb1/Map3k7/Trim32/Sesn2/ Fbxl5/Cnot6l/Hnrnpd/Hmgb1/Zc3hav1/Hk2/Nop53/Supt5/Fgf21/Insr/Cnot7/ Wwp2/Disc1/Sorl1/Vps11/Nedd4/Hdac6"" 62" "GO:0003007 ""GO:0003007"" ""heart morphogenesis"" ""47/1866"" ""274/23239"" 5.72543154132114e-07 0.000171582143138329 0.000139408707058761 ""Fhl2/Bmpr2/Mdm4/Cited2/Ahi1/Gja1/Sirt6/Tmem100/ Med1/Rara/Axin2/Flrt2/Ptch1/Mef2c/Zmiz1/Fgf9/Gata4/Mir17/Zfpm2/Tab1/ Mkl2/Hes1/Robo2/Erg/Sos1/Smad7/Kdm2a/Notch2/Rbm15/Jun/Myom3/Fzd1/ Sema3c/Tbx5/Tmed2/Ncor2/Smo/Wnt11/Folr1/Tead1/Insr/Myom2/Dlc1/Cpe/ Yap1/Nedd4/Ctnnb1"" 47" "GO:0048588 ""GO:0048588"" ""developmental cell growth"" ""44/1866"" ""252/23239"" 7.8921635972867e-07 0.000224689897614752 0.000182558205316184 ""Bmpr2/Actr3/Cxcr4/Rgs2/Sirt1/Sirt6/Fstl4/Itsn2/ Akap6/Hnrnpk/Vcl/Gata4/Dpysl2/Sema5b/App/Tiam1/Ddr1/Hsp90ab1/Myo5b/ Flrt1/Shtn1/Sema6d/Cpne1/Adnp/Sema6c/Ngf/Pdlim5/Sh3glb1/Epha7/Sema3c/ Nkx6-1/Smo/Plxna1/Akap13/Sema4b/Picalm/Nrg1/Pou4f2/Disc1/Sema7a/ Rab11a/Clasp2/Ctnnb1/Hdac6"" 44" "GO:0021915 ""GO:0021915"" ""neural tube development"" ""36/1866"" ""190/23239"" 1.08165923182003e-06 0.000293284174570631 0.00023829034204757 ""Traf3ip1/Enah/Cited2/Nf1/Rara/Zfp36l1/Rala/ Ptch1/Fzd3/Scrib/Nup50/Prickle1/Hes1/Ift140/Tgif1/Kdm2a/Pax2/Tcf7l2/ Bmi1/Nckap1/Ambra1/Lmo4/Map3k7/Arid1a/Fzd1/Sema3c/Wdr19/Kdm2b/Tmed2/ Smo/Arhgap35/Folr1/Adm/Dlc1/Prkaca/Nup133"" 36" "GO:0035265 ""GO:0035265"" ""organ growth"" ""38/1866"" ""209/23239"" 1.5865103698161e-06 0.000336192293737761 0.00027315274267973 ""Erbb4/ Rgs2/Kcnk2/Cited2/Map7/Hdac2/Gja1/Psap/Sirt1/Sirt6/Dusp6/Anxa6/Rara/ Akap6/Mef2c/Lats2/Fgf9/Gata4/Prlr/Zfpm2/Rxrb/Fgf1/Tcf7l2/Wt1/Pdlim5/ Col27a1/Acacb/Tbx5/Ptpn11/Smo/Ube3a/Akap13/Tenm4/Yap1/1190002N15Rik/ Poc1a/Ctnnb1/Ar"" 38" "GO:0033044 ""GO:0033044"" ""regulation of chromosome organization"" ""54/1866"" ""346/23239"" 1.84020761685198e-06 0.00037421936322697 0.00030404934120543 ""Zfp451/Hecw2/Xrcc5/Trip12/Hnrnpu/Nek2/Sirt1/ Sirt6/Lif/Pttg1/Srebf1/Cenpv/Ctc1/Aurkb/Smg6/Tex14/Axin2/H3f3b/Wbp2/ Prkd1/Jdp2/Hist1h1c/Rad21/Mtbp/Slx4/Ercc4/Kat2b/Fshr/Kdm2a/Tnks2/Slf2/ Stn1/Rif1/Tlk1/Nat10/Eid1/Zfp335/Dhx36/Setdb1/Cdk5rap2/Paxip1/Hnrnpd/ Mtf2/Sart3/Mapkapk5/Anapc5/Mad1l1/Kdm3a/Lrrk1/Setd1a/Bub3/Mki67/ Ctnnb1/Phf8"" 54" "GO:0017148 ""GO:0017148"" ""negative regulation of translation"" ""28/1866"" ""133/23239"" 1.9631743065219e-06 0.000385459120735714 0.00031318152730177 ""Gigyf2/Rgs2/Rc3h1/Cnot2/Eif4enif1/Larp1/Cnot8/ Rara/Zfp36l1/Enc1/Ang/Rnf139/Tnrc6b/Zfp36l2/Cpeb3/Wt1/Fxr1/Dhx36/ Mov10/Mettl14/Eif4e/Sesn2/Cnot6l/Hnrnpd/Tia1/Samd4b/Rpl13a/Cnot7"" 28" "GO:0048638 ""GO:0048638"" ""regulation of developmental growth""
Load more

Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • DNA Methylation Regulates Discrimination of Enhancers From
    Sharifi-Zarchi et al. BMC Genomics (2017) 18:964 DOI 10.1186/s12864-017-4353-7 RESEARCHARTICLE Open Access DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism Ali Sharifi-Zarchi1,2,3,4†, Daniela Gerovska5†, Kenjiro Adachi6, Mehdi Totonchi3, Hamid Pezeshk7,8, Ryan J. Taft9, Hans R. Schöler6,10, Hamidreza Chitsaz2, Mehdi Sadeghi8,11, Hossein Baharvand3,12* and Marcos J. Araúzo-Bravo5,13,14* Abstract Background: DNA methylation at promoters is largely correlated with inhibition of gene expression. However, the role of DNA methylation at enhancers is not fully understood, although a crosstalk with chromatin marks is expected. Actually, there exist contradictory reports about positive and negative correlations between DNA methylation and H3K4me1, a chromatin hallmark of enhancers. Results: We investigated the relationship between DNA methylation and active chromatin marks through genome- wide correlations, and found anti-correlation between H3K4me1 and H3K4me3 enrichment at low and intermediate DNA methylation loci. We hypothesized “seesaw” dynamics between H3K4me1 and H3K4me3 in the low and intermediate DNA methylation range, in which DNA methylation discriminates between enhancers and promoters, marked by H3K4me1 and H3K4me3, respectively. Low methylated regions are H3K4me3 enriched, while those with intermediate DNA methylation levels are progressively H3K4me1 enriched. Additionally, the enrichment of H3K27ac, distinguishing active from primed enhancers, follows a plateau in the lower range of the intermediate DNA methylation level, corresponding to active enhancers, and decreases linearly in the higher range of the intermediate DNA methylation. Thus, the decrease of the DNA methylation switches smoothly the state of the enhancers from a primed to an active state.
    [Show full text]
  • Structural Characterization of the Human Eukaryotic Initiation Factor 3 Protein Complex by Mass Spectrometry*□S
    Supplemental Material can be found at: http://www.mcponline.org/cgi/content/full/M600399-MCP200 /DC1 Research Structural Characterization of the Human Eukaryotic Initiation Factor 3 Protein Complex by Mass Spectrometry*□S Eugen Damoc‡, Christopher S. Fraser§, Min Zhou¶, Hortense Videler¶, Greg L. Mayeurʈ, John W. B. Hersheyʈ, Jennifer A. Doudna§, Carol V. Robinson¶**, and Julie A. Leary‡ ‡‡ Protein synthesis in mammalian cells requires initiation The initiation phase of eukaryotic protein synthesis involves factor eIF3, an ϳ800-kDa protein complex that plays a formation of an 80 S ribosomal complex containing the initi- Downloaded from central role in binding of initiator methionyl-tRNA and ator methionyl-tRNAi bound to the initiation codon in the mRNA to the 40 S ribosomal subunit to form the 48 S mRNA. This is a multistep process promoted by proteins initiation complex. The eIF3 complex also prevents pre- called eukaryotic initiation factors (eIFs).1 Currently at least 12 mature association of the 40 and 60 S ribosomal subunits eIFs, composed of at least 29 distinct subunits, have been and interacts with other initiation factors involved in start identified (1). Mammalian eIF3, the largest initiation factor, is a codon selection. The molecular mechanisms by which multisubunit complex with an apparent molecular mass of www.mcponline.org eIF3 exerts these functions are poorly understood. Since ϳ800 kDa. This protein complex plays an essential role in its initial characterization in the 1970s, the exact size, translation by binding directly to the 40 S ribosomal subunit composition, and post-translational modifications of and promoting formation of the 43 S preinitiation complex ⅐ ⅐ mammalian eIF3 have not been rigorously determined.
    [Show full text]
  • Amplitude Modulation of Androgen Signaling by C-MYC
    Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Amplitude modulation of androgen signaling by c-MYC Min Ni,1,2 Yiwen Chen,3,4 Teng Fei,1,2 Dan Li,1,2 Elgene Lim,1,2 X. Shirley Liu,3,4,5 and Myles Brown1,2,5 1Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; 2Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA; 3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; 4Harvard School of Public Health, Boston, Massachusetts 02215, USA Androgen-stimulated growth of the molecular apocrine breast cancer subtype is mediated by an androgen receptor (AR)-regulated transcriptional program. However, the molecular details of this AR-centered regulatory network and the roles of other transcription factors that cooperate with AR in the network remain elusive. Here we report a positive feed-forward loop that enhances breast cancer growth involving AR, AR coregulators, and downstream target genes. In the absence of an androgen signal, TCF7L2 interacts with FOXA1 at AR-binding sites and represses the basal expression of AR target genes, including MYC. Direct AR regulation of MYC cooperates with AR-mediated activation of HER2/HER3 signaling. HER2/HER3 signaling increases the transcriptional activity of MYC through phosphorylation of MAD1, leading to increased levels of MYC/MAX heterodimers. MYC in turn reinforces the transcriptional activation of androgen-responsive genes. These results reveal a novel regulatory network in molecular apocrine breast cancers regulated by androgen and AR in which MYC plays a central role as both a key target and a cooperating transcription factor to drive oncogenic growth.
    [Show full text]
  • An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis Sriram Devanathan Washington University School of Medicine in St. Louis Timothy Whitehead Washington University School of Medicine in St. Louis George G. Schweitzer Washington University School of Medicine in St. Louis Nicole Fettig Washington University School of Medicine in St. Louis Attila Kovacs Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; and Shoghi, Kooresh I., ,"An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis." PLoS One.9,7. e101900. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3326 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Sriram Devanathan, Timothy Whitehead, George G. Schweitzer, Nicole Fettig, Attila Kovacs, Kenneth S. Korach, Brian N. Finck, and Kooresh I. Shoghi This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3326 An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis Sriram Devanathan1, Timothy Whitehead1, George G. Schweitzer2, Nicole Fettig1, Attila Kovacs3, Kenneth S.
    [Show full text]
  • UNIVERSITY of CALIFORNIA Los Angeles
    UNIVERSITY OF CALIFORNIA Los Angeles Dissecting transcriptional control by Klf4 in somatic cell reprogramming A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biological Chemistry by Huajun Zhou 2017 ABSTRACT OF THE DISSERTATION Dissecting transcriptional control by Klf4 in somatic cell reprogramming by Huajun Zhou Doctor of Philosophy in Biological Chemistry University of California, Los Angeles, 2017 Professor Gregory S. Payne, Chair Ectopic expression of four transcription factors, Oct4, Sox2, Klf4, and c-Myc, coverts somatic cells directly into induced pluripotent stem cells (iPSCs), which are functionally equivalent to embryonic stem cells (ESCs). The discovery of iPSC has been reshaping the methodology of disease modeling and drug screening in the past decade, and provides tremendous promise for regenerative medicine. However, the mechanism underlying this conversion process, reprogramming, is not yet fully understood. I aimed to dissect the reprogramming process, by characterizing the functional domains of one reprogramming factor Klf4. The transcriptional activation domain (TAD) of Klf4 was revealed to be critical for reprogramming. To search for the factors that mediates the functionality of Klf4 TAD, I identified transcriptional coactivators CBP/p300 and Mediator complex as the physical interaction partners of Klf4 TAD, and further showed that this interaction is functionally required ii for Klf4 mediated transcriptional activation in reprograming. Clathrin heavy chain, initially identified as a physical interaction partner of Klf4 TAD, was shown to be not required for Klf4 transcriptional activation. Clathrin heavy chain was furthered characterized for its potential transcriptional activation activity in CHC-TFE3, a chromosomal fusion discovered in renal cell carcinoma.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]
  • The Yeast Eif3 Subunits TIF32/A, NIP1/C, and Eif5 Make Critical Connections with the 40Sribosome in Vivo
    Downloaded from genesdev.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press The yeast eIF3 subunits TIF32/a, NIP1/c, and eIF5 make critical connections with the 40Sribosome in vivo Leoš Valášek, Amy A. Mathew, Byung-Sik Shin, Klaus H. Nielsen, Béla Szamecz, and Alan G. Hinnebusch1 Laboratory of Gene Regulation and Development, National Institute of Child Health and Human Development, Bethesda, Maryland 20892, USA Initiation factor 3 (eIF3) forms a multifactor complex (MFC) with eIF1, eIF2, and eIF5 that stimulates Met Met-tRNAi binding to 40Sribosomes and promotes scanning or AUG recognition. We have previously characterized MFC subcomplexes produced in vivo from affinity-tagged eIF3 subunits lacking discrete binding domains for other MFC components. Here we asked whether these subcomplexes can bind to 40Sribosomes in vivo. We found that the N- and C-terminal domains of NIP1/eIF3c, the N- and C-terminal domains of TIF32/eIF3a, and eIF5 have critical functions in 40Sbinding, with eIF5 an d the TIF32-CTD performing redundant functions. The TIF32-CTD interacted in vitro with helices 16–18 of domain I in 18SrRNA, and the TIF32-NTD and NIP1 interacted with 40Sprotein RPS0A.These results sugge st that eIF3 binds to the solvent side of the 40Ssubunit in a way that provides access to the interface side fo r the two eIF3 segments Met (NIP1-NTD and TIF32-CTD) that interact with eIF1, eIF5, and the eIF2/GTP/Met-tRNAi ternary complex. [Keywords: Eukaryotic translation initiation factor (eIF); multifactor complex (MFC); translational control; protein synthesis; 40S ribosome binding; TIF32/NIP1] Supplemental material is available at http://www.genesdev.org.
    [Show full text]
  • Understanding Chronic Kidney Disease: Genetic and Epigenetic Approaches
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2017 Understanding Chronic Kidney Disease: Genetic And Epigenetic Approaches Yi-An Ko Ko University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Bioinformatics Commons, Genetics Commons, and the Systems Biology Commons Recommended Citation Ko, Yi-An Ko, "Understanding Chronic Kidney Disease: Genetic And Epigenetic Approaches" (2017). Publicly Accessible Penn Dissertations. 2404. https://repository.upenn.edu/edissertations/2404 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2404 For more information, please contact [email protected]. Understanding Chronic Kidney Disease: Genetic And Epigenetic Approaches Abstract The work described in this dissertation aimed to better understand the genetic and epigenetic factors influencing chronic kidney disease (CKD) development. Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) significantly associated with chronic kidney disease. However, these studies have not effectively identified target genes for the CKD variants. Most of the identified variants are localized to non-coding genomic regions, and how they associate with CKD development is not well-understood. As GWAS studies only explain a small fraction of heritability, we hypothesized that epigenetic changes could explain part of this missing heritability. To identify potential gene targets of the genetic variants, we performed expression quantitative loci (eQTL) analysis, using genotyping arrays and RNA sequencing from human kidney samples. To identify the target genes of CKD-associated SNPs, we integrated the GWAS-identified SNPs with the eQTL results using a Bayesian colocalization method, coloc. This resulted in a short list of target genes, including PGAP3 and CASP9, two genes that have been shown to present with kidney phenotypes in knockout mice.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Supplementary Material
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Page 1 / 45 SUPPLEMENTARY MATERIAL Appendix A1: Neuropsychological protocol. Appendix A2: Description of the four cases at the transitional stage. Table A1: Clinical status and center proportion in each batch. Table A2: Complete output from EdgeR. Table A3: List of the putative target genes. Table A4: Complete output from DIANA-miRPath v.3. Table A5: Comparison of studies investigating miRNAs from brain samples. Figure A1: Stratified nested cross-validation. Figure A2: Expression heatmap of miRNA signature. Figure A3: Bootstrapped ROC AUC scores. Figure A4: ROC AUC scores with 100 different fold splits. Figure A5: Presymptomatic subjects probability scores. Figure A6: Heatmap of the level of enrichment in KEGG pathways. Kmetzsch V, et al. J Neurol Neurosurg Psychiatry 2021; 92:485–493. doi: 10.1136/jnnp-2020-324647 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Appendix A1. Neuropsychological protocol The PREV-DEMALS cognitive evaluation included standardized neuropsychological tests to investigate all cognitive domains, and in particular frontal lobe functions. The scores were provided previously (Bertrand et al., 2018). Briefly, global cognitive efficiency was evaluated by means of Mini-Mental State Examination (MMSE) and Mattis Dementia Rating Scale (MDRS). Frontal executive functions were assessed with Frontal Assessment Battery (FAB), forward and backward digit spans, Trail Making Test part A and B (TMT-A and TMT-B), Wisconsin Card Sorting Test (WCST), and Symbol-Digit Modalities test.
    [Show full text]